Amneal Pharmaceuticals (AMRX) Revenue Growth (5y) (2022 - 2026)
Amneal Pharmaceuticals (AMRX) Revenue Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.67 Bn | 5.66 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.94% |
| Dec 31, 2025 | 21.93% |
| Sep 30, 2025 | 8.60% |
| Jun 30, 2025 | 9.29% |
| Mar 31, 2025 | 6.88% |
| Dec 31, 2024 | 12.95% |
| Sep 30, 2024 | 13.18% |
| Jun 30, 2024 | 11.64% |
| Mar 31, 2024 | 8.12% |
| Dec 31, 2023 | 4.40% |
| Sep 30, 2023 | 5.41% |
| Jun 30, 2023 | 7.68% |
| Mar 31, 2023 | 15.17% |
| Dec 31, 2022 | -49.21% |
| Sep 30, 2022 | 16.45% |
| Jun 30, 2022 | 16.57% |